Comorbid illness in women with chronic fatigue syndrome: a test of the single syndrome hypothesis.
Ciccone, Donald S, Natelson, Benjamin H · Psychosomatic medicine · 2003 · DOI
Quick Summary
This study looked at 163 women with ME/CFS to see whether having other conditions like fibromyalgia or chemical sensitivities alongside ME/CFS made their illness different. About a third of the women had fibromyalgia, and another third had chemical sensitivities. The main finding was that women with multiple conditions were more likely to have depression than those with ME/CFS alone, but otherwise their symptoms and disability levels were fairly similar.
Why It Matters
Understanding whether ME/CFS, fibromyalgia, and chemical sensitivities are variants of one condition or separate disorders affects how clinicians diagnose and treat patients. This study demonstrates that psychiatric comorbidity increases substantially with multiple unexplained syndromes, highlighting the need for comprehensive mental health screening in complex cases and informing whether unified or syndrome-specific treatment approaches may be more effective.
Observed Findings
37% of women with CFS met criteria for fibromyalgia, and 33% met criteria for multiple chemical sensitivities.
Lifetime major depression prevalence increased from 27.4% (CFS only) to 52.3% (CFS/FM), 45.2% (CFS/MCS), and 69.2% (CFS/FM/MCS).
Fibromyalgia-related pain and disability significantly distinguished CFS/FM groups from CFS-only group.
Patients with comorbid conditions had significantly higher psychiatric morbidity risk than CFS-only patients (p<.01).
Except for FM-related symptoms, few differences in overall symptom severity were found between groups.
Inferred Conclusions
High prevalence of comorbidity among unexplained illness syndromes provides partial support for the hypothesis that they may represent variants of a single functional disorder.
The strong association between increasing comorbidity burden and major depression suggests psychiatric morbidity is a correlate or consequence of multiple concurrent unexplained syndromes.
Discrete diagnostic labels may not substantially differentiate symptom profiles except in pain-related domains, questioning the clinical utility of separate case definitions.
Remaining Questions
Does depression precede, follow, or co-develop with comorbid unexplained syndromes, or do all share a common biological etiology?
What This Study Does Not Prove
This cross-sectional study cannot establish causation—it does not prove whether depression causes comorbidity, comorbidity causes depression, or both share a common underlying biological mechanism. The study also uses retrospective diagnostic assignment and self-report questionnaires, which may introduce recall bias and cannot definitively rule out that the conditions are discrete disorders or that they represent a single process. These findings are specific to women and may not generalize to men with ME/CFS.
Tags
Symptom:PainFatigueSensory Sensitivity
Method Flag:PEM Not DefinedWeak Case DefinitionNo ControlsExploratory Only
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Why do some patients develop multiple syndromes while others develop only one, and what biological or environmental factors drive this differentiation?
Do the findings in women extend to men with ME/CFS, or are there sex-specific patterns in comorbidity and psychiatric risk?
Would prospective or longitudinal follow-up reveal differences in symptom progression, treatment response, or outcomes between CFS-only and comorbid groups?